Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Undisclosed
Therapeutic Area : Psychiatry/Psychology
Study Phase : Preclinical
Sponsor : Jaguar Health
Deal Size : Inapplicable
Deal Type : Inapplicable
Magdalena Biosciences Reports Psychoactive Activity Of Medicinal Plant
Details : Magdalena is developing novel, plant-derived prescription medicines for mental health, including ADHD in adults, social anxiety, and depression.
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
January 30, 2024
Lead Product(s) : Undisclosed
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Preclinical
Sponsor : Jaguar Health
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Undisclosed
Therapeutic Area : Psychiatry/Psychology
Study Phase : Undisclosed
Sponsor : One Small Planet
Deal Size : $1.0 million
Deal Type : Financing
Details : The net proceeds will be used to develop novel, natural prescription medicines derived from plants for mental health indications such as depression, anxiety, attention-deficit/hyperactivity disorder (ADHD) and other possible neuropsychiatric conditions i...
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
October 30, 2023
Lead Product(s) : Undisclosed
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Undisclosed
Sponsor : One Small Planet
Deal Size : $1.0 million
Deal Type : Financing